2023
Treatment of Stiff-Person Syndrome with Botulinum Toxin
Safarpour D, Jabbari B. Treatment of Stiff-Person Syndrome with Botulinum Toxin. 2023, 174-179. DOI: 10.1017/9781009105033.021.Peer-Reviewed Original ResearchBotulinum toxinStiff-person syndromeBotulinum toxin therapyToxin therapyToxin formulationsBedside guidanceInjection siteCosmetic treatmentCadaveric dissectionAnatomical landmarksSmile correctionToxinTreatmentEyesInjectionClinician's eyeLower facePathophysiologySyndromeTherapyCliniciansPhysiciansDissectionTreatment of Plantar Fasciitis/Plantar Fasciopathy with Botulinum Neurotoxins
Safarpour D, Mittal S, Jabbari B. Treatment of Plantar Fasciitis/Plantar Fasciopathy with Botulinum Neurotoxins. 2023, 269-274. DOI: 10.1017/9781009105033.034.Peer-Reviewed Original ResearchBotulinum toxinBotulinum toxin therapyPlantar FasciopathyToxin therapyToxin formulationsBedside guidanceInjection siteCosmetic treatmentCadaveric dissectionAnatomical landmarksSmile correctionBotulinum neurotoxinToxinTreatmentEyesInjectionClinician's eyeLower facePathophysiologyTherapyCliniciansPhysiciansDissection
2013
Hyperhidrosis: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins
Lakraj AA, Moghimi N, Jabbari B. Hyperhidrosis: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins. Toxins 2013, 5: 821-840. PMID: 23612753, PMCID: PMC3705293, DOI: 10.3390/toxins5040821.Peer-Reviewed Original ResearchConceptsClass II studiesII studyAxillary hyperhidrosisPalmar hyperhidrosisComparator studiesBotulinum toxinClass IEvidence level BLevel of evidenceClass III studiesOral agentsIII studyClinical featuresTopical agentsComparable efficacyLong lasting effectInjection sessionsBlinded studyAmerican AcademyDrug efficacyClass IIHyperhidrosisEfficacyWorld literatureToxin